Filed before 2025Filed 12 October 2023
CuraSen Therapeutics, Inc. has sold $17.6M so far
CuraSen Therapeutics, Inc., a biotech company based in San Carlos, CA, has sold $17.6M so far in its equity round, according to a filing dated 12 October 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 October 2023
- First filed
- 10 November 2022
- Round
- Equity round (amended filing)
- Amount sold
- $17.6M
- Offering size
- $20.8M
- Investors so far
- 11
- Based in
- San Carlos, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 76% of the 1,396 tracked raises with an amount filed in 2023, and than 58% of the 142 in biotech.
CuraSen Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 18 Sep 2024 | New filing | $5.79M | Another raise |
| 12 Oct 2023 | Amended filing | $17.6M | This raise |
| 10 Nov 2022 | New filing | $15M | This raise |
| 5 Nov 2021 | New filing | $18M | Another raise |
| 25 Jan 2019 | New filing | $27.2M | Another raise |
More with Longitude on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.